@article{goring_dapagliflozin_2014-1,
	title = {Dapagliflozin compared with other oral anti-diabetes treatments when added to metformin monotherapy: a systematic review and network meta-analysis},
	volume = {16},
	number = {5},
	journal = {Diabetes, Obesity and Metabolism},
	author = {Goring, S and Hawkins, N and Wygant, G and Roudaut, M and Townsend, R and Wood, I and Barnett, AH},
	year = {2014},
	keywords = {Administration, Benzhydryl Compounds, Blood Glucose, Body Weight, Combination, Diabetes Mellitus, Dipeptidyl-Peptidase IV Inhibitors, Drug Therapy, Female, Glucosides, Glycated Hemoglobin A, Humans, Hypoglycemia, Hypoglycemic Agents, Male, meta-analysis, metformin, Metformin, Middle Aged, Oral, Randomized Controlled Trials as Topic, SGLT2 inhibitor, Sulfonylurea Compounds, Thiazolidinediones, Treatment Outcome, Type 2, type 2 diabetes},
	pages = {433--442},
	file = {Snapshot:/Users/neil.hawkins/Zotero/storage/MGPVUNQH/dom.html:text/html},
}

{"_id":"LDwsi9xNBuZ8kHrft","bibbaseid":"goring-hawkins-wygant-roudaut-townsend-wood-barnett-dapagliflozincomparedwithotheroralantidiabetestreatmentswhenaddedtometforminmonotherapyasystematicreviewandnetworkmetaanalysis-2014","authorIDs":[],"author_short":["Goring, S","Hawkins, N","Wygant, G","Roudaut, M","Townsend, R","Wood, I","Barnett, A."],"bibdata":{"bibtype":"article","type":"article","title":"Dapagliflozin compared with other oral anti-diabetes treatments when added to metformin monotherapy: a systematic review and network meta-analysis","volume":"16","number":"5","journal":"Diabetes, Obesity and Metabolism","author":[{"propositions":[],"lastnames":["Goring"],"firstnames":["S"],"suffixes":[]},{"propositions":[],"lastnames":["Hawkins"],"firstnames":["N"],"suffixes":[]},{"propositions":[],"lastnames":["Wygant"],"firstnames":["G"],"suffixes":[]},{"propositions":[],"lastnames":["Roudaut"],"firstnames":["M"],"suffixes":[]},{"propositions":[],"lastnames":["Townsend"],"firstnames":["R"],"suffixes":[]},{"propositions":[],"lastnames":["Wood"],"firstnames":["I"],"suffixes":[]},{"propositions":[],"lastnames":["Barnett"],"firstnames":["AH"],"suffixes":[]}],"year":"2014","keywords":"Administration, Benzhydryl Compounds, Blood Glucose, Body Weight, Combination, Diabetes Mellitus, Dipeptidyl-Peptidase IV Inhibitors, Drug Therapy, Female, Glucosides, Glycated Hemoglobin A, Humans, Hypoglycemia, Hypoglycemic Agents, Male, meta-analysis, metformin, Metformin, Middle Aged, Oral, Randomized Controlled Trials as Topic, SGLT2 inhibitor, Sulfonylurea Compounds, Thiazolidinediones, Treatment Outcome, Type 2, type 2 diabetes","pages":"433–442","file":"Snapshot:/Users/neil.hawkins/Zotero/storage/MGPVUNQH/dom.html:text/html","bibtex":"@article{goring_dapagliflozin_2014-1,\n\ttitle = {Dapagliflozin compared with other oral anti-diabetes treatments when added to metformin monotherapy: a systematic review and network meta-analysis},\n\tvolume = {16},\n\tnumber = {5},\n\tjournal = {Diabetes, Obesity and Metabolism},\n\tauthor = {Goring, S and Hawkins, N and Wygant, G and Roudaut, M and Townsend, R and Wood, I and Barnett, AH},\n\tyear = {2014},\n\tkeywords = {Administration, Benzhydryl Compounds, Blood Glucose, Body Weight, Combination, Diabetes Mellitus, Dipeptidyl-Peptidase IV Inhibitors, Drug Therapy, Female, Glucosides, Glycated Hemoglobin A, Humans, Hypoglycemia, Hypoglycemic Agents, Male, meta-analysis, metformin, Metformin, Middle Aged, Oral, Randomized Controlled Trials as Topic, SGLT2 inhibitor, Sulfonylurea Compounds, Thiazolidinediones, Treatment Outcome, Type 2, type 2 diabetes},\n\tpages = {433--442},\n\tfile = {Snapshot:/Users/neil.hawkins/Zotero/storage/MGPVUNQH/dom.html:text/html},\n}\n\n","author_short":["Goring, S","Hawkins, N","Wygant, G","Roudaut, M","Townsend, R","Wood, I","Barnett, A."],"bibbaseid":"goring-hawkins-wygant-roudaut-townsend-wood-barnett-dapagliflozincomparedwithotheroralantidiabetestreatmentswhenaddedtometforminmonotherapyasystematicreviewandnetworkmetaanalysis-2014","role":"author","urls":{},"keyword":["Administration","Benzhydryl Compounds","Blood Glucose","Body Weight","Combination","Diabetes Mellitus","Dipeptidyl-Peptidase IV Inhibitors","Drug Therapy","Female","Glucosides","Glycated Hemoglobin A","Humans","Hypoglycemia","Hypoglycemic Agents","Male","meta-analysis","metformin","Metformin","Middle Aged","Oral","Randomized Controlled Trials as Topic","SGLT2 inhibitor","Sulfonylurea Compounds","Thiazolidinediones","Treatment Outcome","Type 2","type 2 diabetes"],"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/f/FfNE7kWA6pCvwcJZF/myPubs.bib","creationDate":"2019-08-23T16:16:35.494Z","downloads":0,"keywords":["administration","benzhydryl compounds","blood glucose","body weight","combination","diabetes mellitus","dipeptidyl-peptidase iv inhibitors","drug therapy","female","glucosides","glycated hemoglobin a","humans","hypoglycemia","hypoglycemic agents","male","meta-analysis","metformin","metformin","middle aged","oral","randomized controlled trials as topic","sglt2 inhibitor","sulfonylurea compounds","thiazolidinediones","treatment outcome","type 2","type 2 diabetes"],"search_terms":["dapagliflozin","compared","oral","anti","diabetes","treatments","added","metformin","monotherapy","systematic","review","network","meta","analysis","goring","hawkins","wygant","roudaut","townsend","wood","barnett"],"title":"Dapagliflozin compared with other oral anti-diabetes treatments when added to metformin monotherapy: a systematic review and network meta-analysis","year":2014,"dataSources":["sMi9tjFo5gDXmBZje","t2Yoxo7tWvphNtRzd","ZaHtWavQhcwZqKLNF","dKPQSqAsJNG2yGZjP","iRRNaRs6FkffgErta","zDtGTy8C9ncqTdQuC","gZzkdjqc3Tjd8fnQA","sRQpsiPcuKR3Gwv8J","zeMwFvgpdRkYAkfoD","v8uQmZsBpiqycmskv"]}